We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

RO4929097 And Exemestane in Treating Pre- and Postmenopausal Patients With Advanced or Metastatic Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01149356
Recruitment Status : Terminated (Manufacturer discontinued drug development.)
First Posted : June 23, 2010
Last Update Posted : May 25, 2015
Information provided by (Responsible Party):
National Cancer Institute (NCI)

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : December 2012
  Study Completion Date : April 2013